⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for carcinoma

Every month we try and update this database with for carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung CancerNCT00001499
Carcinoma, Non-...
Lung Neoplasms
paclitaxel
cisplatin
chest radiother...
- National Institutes of Health Clinical Center (CC)
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC StudyNCT02793128
Carcinoma, Tran...
Transitional Ce...
UGN-101 instill...
18 Years - UroGen Pharma Ltd.
Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular CarcinomaNCT00051545
Liver Neoplasms
Seocalcitol
18 Years - 75 YearsLEO Pharma
Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal CarcinomatosisNCT00001569
Carcinoma
Peritoneal Neop...
Cisplatin
Paclitaxel
5-FU
- National Institutes of Health Clinical Center (CC)
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerNCT00672009
Prostatic Disea...
Genital Neoplas...
Urogenital Neop...
Genital Disease...
Adenocarcinoma
Prostatic Neopl...
Neoplasms, Glan...
Carcinoma
Ixabepilone
- Cedars-Sinai Medical Center
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.NCT01398306
Carcinoma
Carcinoma, Rena...
Neuroendocrine ...
Carcinoid Tumor
Pancreatic Isle...
Blood sampling ...
18 Years - University Medical Center Groningen
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)NCT04222972
RET-fusion Non ...
Lung Neoplasm
Carcinoma, Non-...
Respiratory Tra...
Thoracic Neopla...
Neoplasms by Si...
Neoplasms
Lung Diseases
Respiratory Tra...
Carcinoma, Bron...
Bronchial Disea...
Head and Neck N...
Adenocarcinoma
Carcinoma
Neoplasms by Hi...
Neoplasms, Germ...
Neoplasms, Nerv...
Pralsetinib
Carboplatin
Cisplatin
Pemetrexed
Pembrolizumab
Gemcitabine
Paclitaxel
Nab-Paclitaxel
18 Years - Hoffmann-La Roche
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)NCT03915184
Multiple Myelom...
zevor-cel
18 Years - 79 YearsCARsgen Therapeutics Co., Ltd.
Study Of AG-013736 In Patients With 131I-Refractory Thyroid CancerNCT00389441
Thyroid Neoplas...
AG-013736
18 Years - Pfizer
A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal AdenocarcinomaNCT04990037
Metastatic Panc...
CAN04
FOLFIRINOX
18 Years - Cantargia AB
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With JelmytoNCT05874921
Urothelial Carc...
Urothelial Carc...
Urothelial Carc...
Urothelial Carc...
Urothelial Canc...
Urothelial Carc...
Carcinoma, Tran...
Transitional Ce...
Jelmyto (mitomy...
18 Years - UroGen Pharma Ltd.
Sym004 Versus TAS-102 in Patients With mCRCNCT03717038
Metastatic Colo...
Colorectal Canc...
Carcinoma
Sym004
TAS-102
18 Years - Symphogen A/S
Itraconazole in Advanced Ovarian CancerNCT05591560
Ovarian Carcino...
Itraconazole ca...
Placebo
18 Years - 65 YearsTanta University
Study Of AG-013736 (Axitinib) In Patients With Advanced Solid TumorsNCT00447005
Carcinoma
Axitinib (AG-01...
20 Years - 75 YearsPfizer
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation TherapyNCT03703297
Small Cell Lung...
Durvalumab
Tremelimumab
Placebo
18 Years - 130 YearsAstraZeneca
A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaNCT02539537
Pancreatic Canc...
Carcinoma
Gemcitabine
Folinic Acid
5-Fluoro-uracil
Oxaliplatin
Irinotecan
L-folinic
18 Years - UNICANCER
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid TumorsNCT01081808
Neoplasms
Tumors
Solid Tumors
Metastatic Canc...
EGFRBi-armed au...
18 Years - Roger Williams Medical Center
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid TumorsNCT05860374
Sarcoma
Carcinoma
Breast Cancer
Pancreatic Canc...
Colorectal Canc...
Gastric Cancer
Liver Cancer
Lung Cancer
Gynecologic Can...
Recombinant onc...
18 Years - 75 YearsShanghai Yunying Medical Technology
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCCNCT00576056
Carcinoma, Hepa...
Sorafenib
TACE
18 Years - 100 YearsUniversity of Pittsburgh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNCT03452774
Cancer, Metasta...
Cancer
Cancer of Pancr...
Cancer of Liver
Cancer of Stoma...
Cancer Liver
Cancer of Rectu...
Cancer of Kidne...
Cancer of Esoph...
Cancer of Cervi...
Cancer of Colon
Cancer of Laryn...
Cancer, Lung
Cancer, Breast
Cancer, Advance...
Cancer Prostate
Cancer of Neck
Cancer of Skin
Neuroendocrine ...
Carcinoma
Mismatch Repair...
BRCA Gene Rearr...
Non Hodgkin Lym...
Leukemia
Non Small Cell ...
Cholangiocarcin...
Glioblastoma
Central Nervous...
Melanoma
Urothelial Carc...
Bladder Cancer
Ovarian Cancer
Endometrial Can...
Testicular Canc...
Breast Cancer
COVID
Myelofibrosis
Myeloproliferat...
Myeloproliferat...
Follicular Lymp...
Mantle Cell Lym...
Marginal Zone L...
Myelodysplastic...
Clinical Trial ...
- Massive Bio, Inc.
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and NeckNCT03708224
Cancer
Carcinoma
Squamous Cell C...
Head and Neck C...
Atezolizumab
Tocilizumab
Tiragolumab
18 Years - University of California, San Francisco
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the LiverNCT01098422
Colorectal Neop...
Liver Neoplasms
Yttrium-90 Radi...
18 Years - University of California, San Diego
A Phase 1/2 Study of BA3071 as Monotherapy and in Combination With a PD-1 Blocking Antibody in Patients With Advanced Solid TumorsNCT05180799
Solid Tumor, Ad...
NSCLC
Urothelial Carc...
Gastric Cancer
Small Cell Lung...
Hepatocellular ...
Cervical Carcin...
Melanoma
Renal Cell Carc...
Carcinoma
BA3071
Nivolumab
Pembrolizumab
18 Years - BioAtla, Inc.
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)NCT00100685
Renal Cell Carc...
Metastases
Volociximab (an...
18 Years - Abbott
Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell CarcinomaNCT04985825
Cutaneous Squam...
Imgatuzumab
18 Years - Centessa Pharmaceuticals plc
Registry Platform Ovarian and Endometrial CancerNCT05129969
Ovarian Cancer
Endometrial Can...
Ovary Neoplasm
Endometrial Neo...
Carcinoma, Ovar...
Carcinoma
Neoplasm, Ovari...
Physician's cho...
18 Years - iOMEDICO AG
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)NCT00100685
Renal Cell Carc...
Metastases
Volociximab (an...
18 Years - Abbott
Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell CarcinomaNCT04985825
Cutaneous Squam...
Imgatuzumab
18 Years - Centessa Pharmaceuticals plc
Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment StrategyNCT01175772
Ovarian Carcino...
Cytophosphan, C...
20 Years - 80 YearsHaEmek Medical Center, Israel
What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid TumorsNCT02840604
Carcinoma
18 Years - 99 YearsCentre Georges Francois Leclerc
A Study of Cixutumumab (IMC-A12) in Islet Cell CancerNCT00781911
Carcinoma
Neuroendocrine ...
Cixutumumab
depot octreotid...
18 Years - Eli Lilly and Company
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced CancerNCT02507544
Carcinoma
Advanced Cancer
TRX-818 capsule...
18 Years - TaiRx, Inc.
Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell CarcinomaNCT00176280
Renal Cell Carc...
Leukine
Dexamethasone
18 Years - University of Kentucky
Analysis of Brain Metastasis in Patients With Lung CancerNCT00071344
Carcinoma, Non-...
- National Institutes of Health Clinical Center (CC)
Sym004 Versus Futuximab or Modotuximab in Patients With mCRCNCT03549338
Metastatic Colo...
Colorectal Canc...
Carcinoma
Sym004
Futuximab
Modotuximab
18 Years - Symphogen A/S
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung CancerNCT02259582
Nonsquamous Non...
Pemetrexed
Carboplatin
demcizumab
21 Years - Mereo BioPharma
Capecitabine and Lenvatinib With External Radiation in Rectal AdenocarcinomaNCT02935309
Rectal Cancer
Rectal Adenocar...
Lenvatinib
Capecitabine
External Radiat...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the BladderNCT02202772
Urothelial Carc...
Cabazitaxel
Gemcitabine
Cisplatin
18 Years - Columbia University
Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.NCT01035229
Carcinoma
Everolimus
Everolimus Plac...
Best Supportive...
18 Years - Novartis
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNCT00887536
Breast Cancer
bevacizumab
docetaxel
doxorubicin
cyclophosphamid...
pegfilgrastim
18 Years - 70 YearsNSABP Foundation Inc
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerNCT04614103
Metastatic Non ...
LN-145
LN-145
18 Years - 70 YearsIovance Biotherapeutics, Inc.
Vaccination With Flt3L, Radiation, and Poly-ICLCNCT03789097
Non-Hodgkin's L...
Metastatic Brea...
Head and Neck S...
Pembrolizumab
Flt3L
Radiation
Poly ICLC
18 Years - Icahn School of Medicine at Mount Sinai
Study of Oral Darinaparsin in Patients With Advanced Solid TumorsNCT01139346
Advanced Solid ...
darinaparsin
18 Years - Alaunos Therapeutics
Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung CancerNCT00365183
Non-Small Cell ...
Motexafin gadol...
18 Years - Pharmacyclics LLC.
ARQ 501 in Combination With Docetaxel in Patients With CancerNCT00099190
Carcinoma
ARQ 501
18 Years - ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung CancerNCT00365183
Non-Small Cell ...
Motexafin gadol...
18 Years - Pharmacyclics LLC.
A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid TumoursNCT02977364
Carcinoma
Solid Tumor, Ad...
HS-10241
18 Years - 65 YearsJiangsu Hansoh Pharmaceutical Co., Ltd.
Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer PatientsNCT03331601
Carcinoma
Receptor, ErbB-...
68GaNOTA-Anti-H...
18 Years - Universitair Ziekenhuis Brussel
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCCNCT01214343
Advanced Hepato...
Carcinoma
Carcinoma, Hepa...
Liver Neoplasms
Neoplasms
Sorafenib with ...
Sorafenib
20 Years - Ministry of Health, Labour and Welfare, Japan
Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.NCT01310894
Prostate Cancer
TOOKAD® Soluble
18 Years - Steba Biotech S.A.
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract CancerNCT02412670
High Grade Uppe...
Methotrexate
Vinblastine
Doxorubicin
Cisplatin
Gemcitabine
Carboplatin
Pegfilgrastim
Nephroureterect...
18 Years - Eastern Cooperative Oncology Group
Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.NCT01310894
Prostate Cancer
TOOKAD® Soluble
18 Years - Steba Biotech S.A.
A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid TumorsNCT01664000
Solid Tumors
thioureidobutyr...
18 Years - Cellceutix Corporation
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract CancersNCT06001658
Pancreatic Canc...
Gemcitabine
Cisplatin
Pembrolizumab
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6NCT03058289
Breast Cancer
Head and Neck C...
Squamous Cell C...
Lymphoma
Pancreatic Canc...
Liver Cancer
Colon Cancer
Lung Cancer
Bile Duct Cance...
Chordoma of Sac...
Sarcoma
INT230-6
anti-PD-1 antib...
anti-CTLA-4 ant...
18 Years - Intensity Therapeutics, Inc.
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)NCT04379596
Gastric Cancer
Fluorouracil (5...
Capecitabine
Durvalumab
Oxaliplatin
Trastuzumab
Trastuzumab der...
Cisplatin
Pembrolizumab
Volrustomig
Rilvegostomig
18 Years - 130 YearsAstraZeneca
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLCNCT02592577
Non-Small Cell ...
Carcinoma
Autologous Gene...
18 Years - Adaptimmune
Registry Platform Ovarian and Endometrial CancerNCT05129969
Ovarian Cancer
Endometrial Can...
Ovary Neoplasm
Endometrial Neo...
Carcinoma, Ovar...
Carcinoma
Neoplasm, Ovari...
Physician's cho...
18 Years - iOMEDICO AG
Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell LineNCT03288298
Tongue Neoplasm...
Carcinoma
luteolin
nano-luteolin
- Cairo University
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaNCT01339975
Carcinoma
Carcinoma Renal...
Kidney Neoplasm...
Kidney Diseases
Chemokines
Biological samp...
Biological samp...
18 Years - University Hospital, Bordeaux
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic CancerNCT05014776
Pancreatic Canc...
Tadalafil
Pembrolizumab
Ipilimumab
CRS-207
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress MarkersNCT02994069
Carcinoma, Squa...
Head and Neck C...
Cisplatin
XRT
18 Years - University of Kentucky
KTP vs CO2 Laser for the Treatment of Laryngeal CarcinomaNCT02672904
Laryngeal Neopl...
CO2 laser
KTP laser
18 Years - Kaplan Medical Center
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)NCT03769467
Nasopharyngeal ...
Nasopharyngeal ...
Epstein-Barr Vi...
Epstein-Barr Vi...
Epstein-Barr Vi...
tabelecleucel
pembrolizumab
12 Years - Atara Biotherapeutics
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced CancerNCT02507544
Carcinoma
Advanced Cancer
TRX-818 capsule...
18 Years - TaiRx, Inc.
Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO )NCT04249895
All Cancer
- Tata Medical Center
Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer PatientsNCT02696525
Carcinoma
Non-small-cell ...
Lung Neoplasms
18 Years - 80 YearsPeking University People's Hospital
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian CancerNCT02440425
Ovarian Cancer
Pembrolizumab
Paclitaxel
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Expanded Access to Ensartinib for Participants With ALK+ NSCLCNCT04146571
Non-Small Cell ...
ALK Gene Rearra...
Ensartinib
18 Years - Xcovery Holdings, Inc.
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal CarcinomaNCT01519869
Primary Periton...
Ovarian Carcino...
Fallopian Tube ...
neoadjuvant che...
18 Years - University of Kentucky
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung CancerNCT00298896
Carcinoma, Smal...
Small Cell Lung...
SNS-595
18 Years - Sunesis Pharmaceuticals
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryNCT02072356
Adult Primary H...
Advanced Adult ...
Localized Unres...
Recurrent Adult...
yttrium Y 90 gl...
laboratory biom...
TheraSphere
8 Years - Ohio State University Comprehensive Cancer Center
Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)NCT00183742
Cancer
Carcinoma
liposomal doxor...
18 Years - University of Southern California
Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal CarcinomaNCT00545545
Recurrent Color...
Progressive Col...
Safety and effi...
Safety and effi...
18 Years - 75 YearsHiberCell, Inc.
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial CancerNCT06317311
Carcinoma
Dostarlimab
Carboplatin
Paclitaxel
18 Years - GlaxoSmithKline
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerNCT05361174
Unresectable Me...
Metastatic Mela...
Stage III Non-s...
Stage IV Non-sm...
IOV-4001
18 Years - Iovance Biotherapeutics, Inc.
Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or PharyngolaryngectomyNCT00396617
Pharyngeal Neop...
Laryngeal Neopl...
Carcinoma
prothesis voice
total laryngect...
18 Years - University Hospital, Strasbourg, France
SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAANCT05848947
Carcinoma
Carcinoma, Hepa...
Liver Neoplasm
99mTc-Macro Alb...
18 Years - Sirtex Medical
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular CarcinomaNCT03908840
Hepatocellular ...
TBI 302
18 Years - Therapure Biopharma Inc
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma PatientsNCT02526953
Anus Neoplasms
Carcinoma, Squa...
Anus Diseases
Neoplasms
Neoplasms, Squa...
Carcinoma
Paclitaxel
Capecitabine
Capecitabine
Mitomycins
Mitomycins
Radiotherapy
18 Years - 70 YearsBlokhin's Russian Cancer Research Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: